Global Isotopes for Nuclear Medicine Industry

Global Isotopes for Nuclear Medicine Industry Research & Trends Analysis Report

Global Isotopes for Nuclear Medicine Industry

Global Isotopes for Nuclear Medicine Industry Research & Trends Analysis Report


Analysis of the Isotopes for Nuclear Medicine Market reveals emerging trends, consumer adoption rates, and competitive strategies among leading manufacturers worldwide.

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

According to A Latest intelligence report published by Market IntelliX, the global market for Isotopes for Nuclear Medicine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Isotopes for Nuclear Medicine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Isotopes for Nuclear Medicine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Stable Isotope segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Isotopes for Nuclear Medicine include NTP Radioisotopes, Medical Isotopes, ITM, Cambridge Isotope Laboratories, CMR, Urenco, Northwest Medical Isotopes and SHINE Medical, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Isotopes for Nuclear Medicine. Report Highlights:

(1) Global Isotopes for Nuclear Medicine market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Isotopes for Nuclear Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Isotopes for Nuclear Medicine market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Isotopes for Nuclear Medicine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Isotopes for Nuclear Medicine segment by type and by application and regional segment by type and by application.

(6) Isotopes for Nuclear Medicine industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Stable Isotope

Radioisotope

Market segment by application, can be divided into

Hospital

Laboratory

Others

Market segment by players, this report covers

NTP Radioisotopes

Medical Isotopes

ITM

Cambridge Isotope Laboratories

CMR

Urenco

Northwest Medical Isotopes

SHINE Medical

1 Market Overview

1.1 Product Overview and Scope of Isotopes for Nuclear Medicine

1.2 Global Isotopes for Nuclear Medicine Market Size and Forecast

1.3 China Isotopes for Nuclear Medicine Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Isotopes for Nuclear Medicine Share in Global Market, 2018-2029

1.4.2 Isotopes for Nuclear Medicine Market Size: China VS Global, 2018-2029

1.5 Isotopes for Nuclear Medicine Market Dynamics

1.5.1 Isotopes for Nuclear Medicine Market Drivers

1.5.2 Isotopes for Nuclear Medicine Market Restraints

1.5.3 Isotopes for Nuclear Medicine Industry Trends

1.5.4 Isotopes for Nuclear Medicine Industry Policy

2 Global Competitive Situation by Company

2.1 Global Isotopes for Nuclear Medicine Revenue by Company (2018-2023)

2.2 Global Isotopes for Nuclear Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Isotopes for Nuclear Medicine Concentration Ratio

2.4 Global Isotopes for Nuclear Medicine Mergers & Acquisitions, Expansion Plans

2.5 Global Isotopes for Nuclear Medicine Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Isotopes for Nuclear Medicine Revenue by Company (2018-2023)

3.2 China Isotopes for Nuclear Medicine Isotopes for Nuclear Medicine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Isotopes for Nuclear Medicine, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Isotopes for Nuclear Medicine Industry Chain

4.2 Isotopes for Nuclear Medicine Upstream Analysis

4.3 Isotopes for Nuclear Medicine Midstream Analysis

4.4 Isotopes for Nuclear Medicine Downstream Analysis

5 Sights by Type

5.1 Isotopes for Nuclear Medicine Classification

5.1.1 Stable Isotope

5.1.2 Radioisotope

5.2 By Type, Global Isotopes for Nuclear Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Isotopes for Nuclear Medicine Revenue, 2018-2029

6 Sights by Application

6.1 Isotopes for Nuclear Medicine Segment by Application

6.1.1 Hospital

6.1.2 Laboratory

6.1.3 Others

6.2 By Application, Global Isotopes for Nuclear Medicine Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Isotopes for Nuclear Medicine Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Isotopes for Nuclear Medicine Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Isotopes for Nuclear Medicine Market Size, 2018-2029

7.3 North America

7.3.1 North America Isotopes for Nuclear Medicine Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Isotopes for Nuclear Medicine Market Size Market Share

7.4 Europe

7.4.1 Europe Isotopes for Nuclear Medicine Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Isotopes for Nuclear Medicine Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Isotopes for Nuclear Medicine Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Isotopes for Nuclear Medicine Market Size Market Share

7.6 South America

7.6.1 South America Isotopes for Nuclear Medicine Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Isotopes for Nuclear Medicine Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Isotopes for Nuclear Medicine Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Isotopes for Nuclear Medicine Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Isotopes for Nuclear Medicine Market Size, 2018-2029

8.3.2 By Company, U.S. Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Isotopes for Nuclear Medicine Market Size, 2018-2029

8.4.2 By Company, Europe Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Isotopes for Nuclear Medicine Market Size, 2018-2029

8.5.2 By Company, China Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.5.3 By Type, China Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Isotopes for Nuclear Medicine Market Size, 2018-2029

8.6.2 By Company, Japan Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Isotopes for Nuclear Medicine Market Size, 2018-2029

8.7.2 By Company, South Korea Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Isotopes for Nuclear Medicine Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Isotopes for Nuclear Medicine Market Size, 2018-2029

8.9.2 By Company, India Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.9.3 By Type, India Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Isotopes for Nuclear Medicine Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Isotopes for Nuclear Medicine Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Isotopes for Nuclear Medicine Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 NTP Radioisotopes

9.1.1 NTP Radioisotopes Company Information, Head Office, Market Area and Industry Position

9.1.2 NTP Radioisotopes Company Profile and Main Business

9.1.3 NTP Radioisotopes Isotopes for Nuclear Medicine Models, Specifications and Application

9.1.4 NTP Radioisotopes Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.1.5 NTP Radioisotopes Recent Developments

9.2 Medical Isotopes

9.2.1 Medical Isotopes Company Information, Head Office, Market Area and Industry Position

9.2.2 Medical Isotopes Company Profile and Main Business

9.2.3 Medical Isotopes Isotopes for Nuclear Medicine Models, Specifications and Application

9.2.4 Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.2.5 Medical Isotopes Recent Developments

9.3 ITM

9.3.1 ITM Company Information, Head Office, Market Area and Industry Position

9.3.2 ITM Company Profile and Main Business

9.3.3 ITM Isotopes for Nuclear Medicine Models, Specifications and Application

9.3.4 ITM Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.3.5 ITM Recent Developments

9.4 Cambridge Isotope Laboratories

9.4.1 Cambridge Isotope Laboratories Company Information, Head Office, Market Area and Industry Position

9.4.2 Cambridge Isotope Laboratories Company Profile and Main Business

9.4.3 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Models, Specifications and Application

9.4.4 Cambridge Isotope Laboratories Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.4.5 Cambridge Isotope Laboratories Recent Developments

9.5 CMR

9.5.1 CMR Company Information, Head Office, Market Area and Industry Position

9.5.2 CMR Company Profile and Main Business

9.5.3 CMR Isotopes for Nuclear Medicine Models, Specifications and Application

9.5.4 CMR Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.5.5 CMR Recent Developments

9.6 Urenco

9.6.1 Urenco Company Information, Head Office, Market Area and Industry Position

9.6.2 Urenco Company Profile and Main Business

9.6.3 Urenco Isotopes for Nuclear Medicine Models, Specifications and Application

9.6.4 Urenco Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.6.5 Urenco Recent Developments

9.7 Northwest Medical Isotopes

9.7.1 Northwest Medical Isotopes Company Information, Head Office, Market Area and Industry Position

9.7.2 Northwest Medical Isotopes Company Profile and Main Business

9.7.3 Northwest Medical Isotopes Isotopes for Nuclear Medicine Models, Specifications and Application

9.7.4 Northwest Medical Isotopes Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.7.5 Northwest Medical Isotopes Recent Developments

9.8 SHINE Medical

9.8.1 SHINE Medical Company Information, Head Office, Market Area and Industry Position

9.8.2 SHINE Medical Company Profile and Main Business

9.8.3 SHINE Medical Isotopes for Nuclear Medicine Models, Specifications and Application

9.8.4 SHINE Medical Isotopes for Nuclear Medicine Revenue and Gross Margin, 2018-2023

9.8.5 SHINE Medical Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Tables & Figures:
Show more
Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Isotopes for Nuclear Medicine Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
Why is the Isotopes for Nuclear Medicine Market trending toward high growth trajectories?
A dynamic process in the Isotopes for Nuclear Medicine Market is initiated by new entrants, including competitors from unrelated industries, in addition to the established players like Cardinal Health, GE Healthcare, IBA Group, Nordion, Lantheus.
What is the Isotopes for Nuclear Medicine Market really preparing for?
Companies in the Isotopes for Nuclear Medicine Industry will need to adapt swiftly to the behavioral changes that are reshaping consumer decision journeys.
What important business segments are segregated by application types in the latest edition of the Isotopes for Nuclear Medicine Market?
The key business segments in the Isotopes for Nuclear Medicine Market are segregated by applications [Cancer Treatment, Medical Imaging, Radiotherapy, Neurology] and types [Technetium-99m, Iodine-131, Lutetium-177, Fluorine-18].
What is the current state of the Isotopes for Nuclear Medicine Industry, and what is the projected growth trajectory through 2030?
In 2024, the Isotopes for Nuclear Medicine Market share surpassed USD xx million, and between 2025 and 2030, it will grow at a CAGR of yy%.
In the current situation, what value does the Isotopes for Nuclear Medicine Market have?
The value of the Isotopes for Nuclear Medicine Market is estimated to be USD XXX million.
What is the estimated global market value of the Isotopes for Nuclear Medicine Market?
The Isotopes for Nuclear Medicine Market is expected to reach a considerable market valuation.